Compassionate use of sodium thiosulfate for children with liver cancer
Treatments studied
Part of Brain & nervous system, Cancer, Ear, nose & throat clinical trials.
This program provides access to sodium thiosulfate (STS) for children with hepatoblastoma who are receiving cisplatin chemotherapy. The drug may help protect the kidneys from cisplatin's side effects, and the goal is to give patients a chance to benefit from this treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Children must be between 1 month and 18 years old.
- They must have standard-risk hepatoblastoma (a type of liver cancer).
- They must be getting cisplatin chemotherapy (a standard cancer drug).
- They must not have received sodium thiosulfate (STS) before.
- They cannot have any allergy to STS or its ingredients.
- They cannot be pregnant or breastfeeding.
- A parent or legal guardian must give written permission.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a medicine called sodium thiosulfate can protect your hearing from the side effects of cisplatin chemotherapy. It is for people with newly diagnosed cancer who are about to receive cisplatin for the first time.
This Phase 3 study tests whether adding sodium thiosulfate during treatment for newly diagnosed medulloblastoma can reduce the risk of hearing loss. It is designed for children and teens whose cancer meets specific low-risk or average-risk tumor and lab features.
This trial tests whether a gel placed in the ear can protect against hearing loss caused by high-dose cisplatin chemotherapy. It is for people with head and neck cancer who are scheduled to receive a certain amount of cisplatin.
This Phase 2 trial tests whether sodium thiosulfate and mannitol can reduce hearing damage (ototoxicity) in adults receiving cisplatin chemotherapy. It may help protect hearing while you get cancer treatment.
This Phase 3 study tests a modified treatment plan for children newly diagnosed with hepatoblastoma, a type of liver cancer. It may help improve how well treatment works and how safely it can be given by using a structured approach.
This trial tests whether adding Pedmark (sodium thiosulfate) to cisplatin chemotherapy can protect hearing in men with stage II or III testicular germ cell tumors. It aims to reduce the risk of drug-related ear damage while still treating the cancer.
Hear when a new Cisplatin-Induced Hearing Loss in Children Who Had Standard-risk Hepatoblastoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.